Current clinical practice of subcutaneous implantable cardioverter-defibrillator: Analysis using the JROAD-DPC database

Current evidence describing the characteristics of subcutaneous implantable cardioverter-defibrillator (S-ICD) therapy, its trend, and perioperative outcomes compared with transvenous implantable cardioverter-defibrillator (TV-ICD) based on a real-world, large-scale database is scarce. The purpose o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Heart rhythm 2022-06, Vol.19 (6), p.909-916
Hauptverfasser: Tonegawa-Kuji, Reina, Inoue, Yuko Y., Nakai, Michikazu, Kanaoka, Koshiro, Sumita, Yoko, Miyazaki, Yuichiro, Wakamiya, Akinori, Shimamoto, Keiko, Ueda, Nobuhiko, Wada, Mitsuru, Yamagata, Kenichiro, Ishibashi, Kohei, Miyamoto, Koji, Nagase, Satoshi, Aiba, Takeshi, Iwanaga, Yoshitaka, Miyamoto, Yoshihiro, Kusano, Kengo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Current evidence describing the characteristics of subcutaneous implantable cardioverter-defibrillator (S-ICD) therapy, its trend, and perioperative outcomes compared with transvenous implantable cardioverter-defibrillator (TV-ICD) based on a real-world, large-scale database is scarce. The purpose of this study was to identify the characteristics of current S-ICD therapy using a nationwide database. A retrospective analysis of ICD implantation was performed using a nationwide database obtained between 2016 and 2020. A total of 8690 patients implanted with ICD (median age 65 [52–72] year; 6902 men; 2021 S-ICD recipients) were analyzed. Younger patients were more prone to have S-ICD (P
ISSN:1547-5271
1556-3871
DOI:10.1016/j.hrthm.2022.02.006